Literature DB >> 11529487

Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements.

J Pei1, Y Akatsuka, C Anasetti, M T Lin, E W Petersdorf, J A Hansen, P J Martin.   

Abstract

Peripheral blood mononuclear cells from a patient who rejected a T-cell-depleted marrow graft showed spontaneous cytotoxic activity specific for HLA-Cw4 and HLA-B35 alloantigens of the donor. T-cell-receptor complementarity-determining region 3 length distributions in a blood sample obtained at the time of rejection generally showed distortions in only 1 or 2 peaks, indicating that recipient T cells with a broad repertoire of antigen receptors survived the pretransplantation conditioning regimen. An HLA-Cw4-specific, CD8 T-cell clone was recovered from a blood sample after rejection. The T-cell-receptor-B gene rearrangement expressed by this clone was not readily detectable in other blood samples drawn before or after the transplantation, indicating that this clone was only 1 of many recipient-derived T cells that recognized HLA alloantigens of the donor. These results demonstrate the role of the HLA-C locus in T-cell-mediated alloimmune responses and add to emerging evidence that indicates the need to evaluate HLA-C compatibility in selecting hematopoietic stem cell donors for patients who have an increased risk of rejection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529487     DOI: 10.1053/bbmt.2001.v7.pm11529487

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  5 in total

1.  Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients.

Authors:  Patricia A Taylor; Michael J Ehrhardt; Matthew M Roforth; Jessica M Swedin; Angela Panoskaltsis-Mortari; Jonathan S Serody; Bruce R Blazar
Journal:  Blood       Date:  2006-10-03       Impact factor: 22.113

Review 2.  HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?

Authors:  Marie-Eve Blais; Tao Dong; Sarah Rowland-Jones
Journal:  Immunology       Date:  2011-03-01       Impact factor: 7.397

3.  Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.

Authors:  R Hanajiri; M Murata; K Sugimoto; M Murase; R Sakemura; T Goto; K Watanabe; N Imahashi; S Terakura; H Ohashi; Y Akatsuka; S Kurahashi; K Miyamura; H Kiyoi; T Nishida; T Naoe
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

Review 4.  Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance?

Authors:  Eun D Lee
Journal:  Placenta       Date:  2017-03-18       Impact factor: 3.481

5.  The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors.

Authors:  Anna Koclega; Miroslaw Markiewicz; Urszula Siekiera; Alicja Dobrowolska; Mizia Sylwia; Monika Dzierzak-Mietla; Patrycja Zielinska; Malgorzata Sobczyk Kruszelnicka; Andrzej Lange; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-10-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.